Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.
Partridge
Savannah C
SC
Department of Radiology, University of Washington School of Medicine, Seattle, Washington 98109-1023, USA. scp3@u.washington.edu
Vanantwerp
Risa K
RK
Doot
Robert K
RK
Chai
Xiaoyu
X
Kurland
Brenda F
BF
Eby
Peter R
PR
Specht
Jennifer M
JM
Dunnwald
Lisa K
LK
Schubert
Erin K
EK
Lehman
Constance D
CD
Mankoff
David A
DA
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000098:blood supply / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology; D003287:Contrast Media; D005260:Female; D019788:Fluorodeoxyglucose F18; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
D003287:Contrast Media; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D019786:Gadolinium DTPA